The Value of Phenotypic Precision Medicine in Prostate Cancer is a research paper published in The Oncologist (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: T32 HG008955
National Institutes of Health
Grant: R01 1R01CA233585-01
National Institutes of Health
Grant: 1R01CA233585-01
Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer
National Institutes of Health
Grant: 5T32HG008955-03
Postdoctoral training in genomic medicine research
FWCI
1.22
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals